TISSUE MICROARRAY

Quebec Breast Cancer Foundation Tissue Microarray Consortium (QBCF-TMAC) for Biomarker Evaluation

QBCF-TMAc Request Form

To submit your completed application, or for more information, please contact Biobanque RRCancer.

To submit your completed application, or for more information, please contact Biobanque RRCancer.
Breast cancer is the most common type of cancer diagnosed in Canadian women. While the mortality associated with it has steadily decreased over the past decades, breast cancer still remains the second leading cause of cancer-related death in women. Individual patient clinical outcomes and treatment options vary widely depending on the specific characteristics of the tumor.
Harmonized and comprehensive clinical data is stored in a central database (ATiM, Advanced Tissue Management, CTRNet). The fields include data regarding initial diagnosis, treatment, and outcome.
The QBCF-TMAC will provide the breast cancer community with a unique resource of breast cancer tissue. By combining clinical data and biomarkers, it will lead to the definition of a nomogram to help patient stratification and influence treatment management decisions. If you would like to access the QBCF-TMAC resource, please download and complete the request form and email it back to qbcftmac@gmail.com along with any additional required documents.

TISSUE MICROARRAY

Canadian Ovarian Experimental Unified Resource (COEUR)

Coeur Request Specimen Form

To submit your completed application, or for more information, please contact Biobanque RRCancer.

“Ovarian cancer is the fifth-leading cause of cancer-related deaths in the western world. In one of every four women diagnosed, the cancer is resistant to standard first-line chemotherapy. In 2009, through a TFRI Translational Research project, leading ovarian cancer researchers and clinicians from across Canada joined forces to develop a biomarker-driven research program.

An essential part of the program is to link together several collections of cancerous tissues and biobanks through a central platform francepharmacie.fr. This platform is the Canadian Ovarian Experimental Unified Resource (COEUR) and will serve as a comprehensive biological and data resource for the entire biomarker program and the wider research community.

COEUR has been created to promote access, ensure quality, and provide standardization of biological material and data resources for biomarker research in ovarian cancer.

The central research platform is based on a retrospective collection of human epithelial ovarian cancer biological material.

Tissue samples include: high grade serous carcinoma; endometrioid carcinoma; clear cell carcinoma; mucinous carcinoma. The research platform also includes collections of other biological material, such as frozen tissues, blood DNA, serum, plasma, ascites fluids, FFPE samples and TMA, with associated clinical data.”

Access the COEUR repository

“To access the repository, researchers should complete an application form, including a study description. Study projects must meet management and study committee scientific criteria and applicants will need to provide a REB approval. COEUR is set up on the principle that biospecimens will be openly shared, so applicants must be willing to deposit results and data in the COEUR repository at the end of the study.”

https://www.tfri.ca/coeur